Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C

Journal of Hepatology

Volumn 43, Issue 3, 2005, Pages 403-410

  Horiike, Shinichiro ^a   Kawanishi, Shosuke ^b   Kaito, Masahiko ^a   Ma, Ning ^b   Tanaka, Hideaki ^a   Fujita, Naoki ^a   Iwasa, Motoh ^a   Kobayashi, Yoshinao ^a   Hiraku, Yusuke ^b   Oikawa, Shinji ^b   Murata, Mariko ^b   Wang, Jinyan ^a   Semba, Reiji ^b   Watanabe, Shozo ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

8 Hydroxy 2 deoxyguanosine; 8 Nitroguanine; Chronic hepatitis C; Hepatitis C virus; Immunohistochemistry; Interferon; Nitrative DNA damage; Oxidative DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; INTERFERON;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LIVER CELL; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GUANINE; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES;

EID: 23444437459     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.03.026     Document Type: Article

References (52)

1. P. Thierry, Y. Man-Fung, R. Vlad, and L.L. Ching Viral hepatitis C Lancet 362 2003 2095 2100
2. IARC Working Group Hepatitis C virus IARC monographs on the evaluation of carcinogenic risks to humans vol. 59 1994 IARC Lyon p. 165-221
3. I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, and C.C. Harris Mutational hotspot in the p53 gene in human hepatocellular carcinoma Nature 350 1991 427 428
4. B. Bressac, M. Kew, J. Wands, and M. Ozturk Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa Nature 350 1991 429 431
5. T. Oda, H. Tsuda, A. Scarpa, M. Sakamoto, and S. Hirohashi p53 gene mutation spectrum in hepatocellular carcinoma Cancer Res 52 1992 6358 6364
6. W.H. Caselmann, and M. Alt Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma J Hepatol 24 1996 61 64
7. H. Kasai, and S. Nishimura Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents Nucleic Acids Res 12 1984 2137 2145
8. F. Farinati, R. Cardin, P. Degan, N. De Maria, F. Robert, and H.T. David Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection Free Radic Biol Med 27 1999 1284 1291
9. K.B. Hahm, K.J. Lee, J.H. Kim, S.W. Cho, and M.H. Chung Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide Dig Dis Sci 43 1998 72 77
10. H. Kasai Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis Mutat Res 387 1997 147 163
11. R. Shimoda, M. Nagashima, M. Sakamoto, N. Yamaguchi, S. Hirohashi, and J. Yokota Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human liver with chronic hepatitis Cancer Res 54 1994 3171 3172
12. R. Cardin, G. Saccoccio, F. Masutti, S. Bellentani, F. Farinati, and C. Tiribelli DNA oxidative damage in leukocytes correlates with the severity of HCV-ralated liver disease: validation in an open population study J Hepatol 34 2001 587 592
13. T. Kitada, S. Seki, S. Iwai, T. Yamada, H. Sakaguti, and K. Wakasa In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease J Hepatol 35 2001 613 618
14. H. Ohshima, M. Tatemichi, and T. Sawa Chemical basis of inflammation-induced carcinogenesis Arch Biochem Biophys 417 2003 3 11
15. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat Rev Cancer 3 2003 276 285
16. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
17. N. Carl Perspective series: nitric oxide and nitric oxide synthases J Clin Invest 100 1997 2417 2423
18. T. Akaike, and H. Maeda Nitric oxide and virus infection Immunology 101 2000 300 308
19. M.A. Rahman, D.K. Dhar, E. Yamaguchi, S. Maruyama, T. Sato, and H. Hayashi Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in angiogenesis of hepatitis C virus-positive cases Clin Cancer Res 7 2001 1325 1332
20. L. McNaughton, L. Puttagunta, M.A. Martinez-Cuesta, N. Kneteman, I. Mayers, and R. Moqbel Distribution of nitric oxide synthase in normal and cirrhotic human liver Proc Natl Acad Sci USA 99 2002 17161 17166
21. M.A. Rahman, I.D. Kyriazanos, T. Ono, A. Yamanoi, H. Kohno, and M. Tsuchiya Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase Int J Cancer 100 2002 152 157
22. T. Akaike, S. Okamoto, T. Sawa, J. Yoshitake, F. Tamura, and K. Ichimori 8-Nitoroguanosine formation in viral pneumonia and its implication for pathogenesis Proc Natl Acad Sci USA 100 2003 685 690
23. S. Pinlaor, P. Yongvanit, Y. Hiraku, N. Ma, R. Semba, and S. Oikawa 8-Nitroguanine formation in the liver of hamster infected with Opisthorchis viverrini Biochem Biophys Res Commun 309 2003 567 571
24. S. Pinlaor, N. Ma, Y. Hiraku, P. Yongvanit, R. Semba, and S. Oikawa Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7, 8-dihydro-2′-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase Carcinogenesis 2004 1535 1542
25. S. Pinlaor, Y. Hiraku, N. Ma, P. Yongvanit, R. Semba, and S. Oikawa Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis Nitric Oxide 11 2004 175 183
26. V.J. Desmet, M. Gerber, J.H. Hoofnagle, M. Manns, and P.J. Scheuer Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520
27. S. Toyokuni, T. Tanaka, Y. Hattori, Y. Nishiyama, A. Yoshida, and K. Uchida Quantitative immunohistochemical determinations of 8-hydroxy-2′- deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model Lab Invest 76 1997 365 374
28. J.E. Crowther, V.K. Kutala, P. Kuppusamy, J.S. Ferguson, A.A. Beharka, and J.L. Zweier Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity J Immunol 172 2004 6866 6874
29. H. Taniai, I.N. Hines, S. Bharwani, R.E. Maloney, Y. Nimura, and B. Gao Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants Hepatology 39 2004 1544 1552
30. S. Kawanishi, Y. Hiraku, and S. Oikawa Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging Mutat Res 488 2001 65 76
31. M. Ichiba, Y. Maeta, T. Mukoyama, T. Saeki, S. Yasui, and T. Kanbe Expression of 8-hydroxy-2′-deoxyguanosine in chronic liver disease and hepatocellular carcinoma Liver Int 23 2003 338 345
32. K. Matsumoto, Y. Satoh, H. Sugo, S. Takamori, K. Kojima, and M. Fukasawa Immunohistochemical study of the relationship between 8-hydroxy-2′- deoxyguanosine levels in noncancerous region and postoperative recurrence of hepatocellular carcinoma in remnant liver Hepatol Res 25 2003 435 441
33. M. Sabina, M. Kawanaka, A. Kamei, A. Izumi, K. Nakata, and G. Niiyama Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C Antioxid Redox Signal 6 2004 19 24
34. J. Kato, M. Kobune, T. Nakamura, G. Kuroiwa, K. Takada, and R. Takimoto Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res 61 2001 8697 8702
35. A.W. Taylor-Robinson, F.Y. Liew, A. Severn, D. Xu, S.J. McSorley, and P. Garside Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells Eur J Immunol 24 1994 980 984
36. C.M. Hsu, J.S. Wang, C.H. Liu, and L.W. Chen Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism Shock 17 2002 280 285
37. G. Lake-Bakaar, D. Sorbi, and V. Mazzoccoli Nitric oxide and chronic HCV and HIV infections Dig Dis Sci 46 2001 1072 1076
38. D.A. Wink, and J.B. Michell Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radic Biol Med 25 1998 434 456
39. S. Inoue, and S. Kawanishi Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide FEBS Lett 371 1995 86 88
40. J.P. Spencer, J. Wong, A. Jenner, O.I. Aruoma, C.E. Cross, and B. Halliwell Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine Chem Res Toxicol 9 1996 1152 1158
41. V. Yermilov, J. Rubio, M. Becchi, M.D. Friesen, B. Pignatelli, and H. Ohshima Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro Carcinogenesis 16 1995 2045 2050
42. Y.S. Hsieh, H.C. Wang, T.H. Tseng, W.C. Chang, and C.J. Wang Gaseous nitric oxide-induced 8-nitroguanine formation in human lung fibroblast cells and cell-free DNA Toxicol Appl Pharmacol 172 2001 210 216
43. M.S. Satoh, and T. Lindahl Enzymatic repair of oxidative DNA damage Cancer Res 54 1994 1899 1901
44. M. Jaiswal, N.F. LaRusso, L.J. Burgart, and G.J. Gores Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 2000 184 190
45. L.A. Loeb, and B.D. Preston Mutagenesis by apurinic/apyrimidinic sites Annu Rev Genet 20 1986 201 230
46. V. Yermilov, J. Rubio, and H. Ohshima Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination FEBS Lett 376 1995 207 210
47. S. Mahmood, M. Kawanaka, A. Kamei, A. Izumi, K. Nakata, and G. Niiyama Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C Antioxid Redox Signal 6 2004 19 24
48. A. Kasahara, N. Hayashi, K. Mochizuki, M. Takayanagi, K. Yoshioka, and S. Kakumu Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group Hepatology 27 1998 1394 1402
49. Y. Imai, S. Kawata, S. Tamura, I. Yabuuchi, S. Noda, and M. Inada Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C Ann Intern Med 129 1998 94 99
50. K. Ikeda, S. Saitoh, Y. Arase, K. Chayama, Y. Suzuki, and M. Kobayashi Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis Hepatology 29 1999 1124 1130
51. H. Yoshida, Y. Shiratori, M. Moriyama, Y. Arakawa, T. Ide, and M. Sata Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan Ann Intern Med 131 1999 174 181
52. N. Ma, Y. Adachi, Y. Hiraku, N. Horiki, S. Horiike, and I. Imoto Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection Biochem Biophys Res Commun 319 2004 506 510